Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R01 Clinical Trial Not Allowed)
Agency: National Institutes of Health
Assistance Listings: 93.855 -- Allergy and Infectious Diseases Research
Description
The purpose of this notice of funding opportunity (NOFO) is to support research to elucidate how HIV-induced immunometabolic alterations, in a host suppressed on combination antiretroviral therapy (cART-suppressed), impact the immune response and increase risk for poor outcomes due to a second, potentially long-term, infection such as Mycobacterium tuberculosis (Mtb) or hepatitis B virus (HBV). This NOFO aims to support research to define how HIV-driven alterations to immunometabolism affect immune cell regulation, cell-cell interactions, response to treatment, and, ultimately, tuberculosis (TB) and HBV disease progression.
Eligibility
Eligible applicants
Business
- For-profit organizations other than small businesses
- Small businesses
Nonprofit
- Nonprofits non-higher education without 501(c)(3)
- Other Native American tribal organizations
- Nonprofits non-higher education with 501(c)(3)
Government
- County governments
- Public and Indian housing authorities
- Federally recognized Native American tribal governments
- State governments
- Special district governments
- City or township governments
Miscellaneous
- Other
Education
- Independent school districts
- Private institutions of higher education
- Public and state institutions of higher education
Additional information
Grantor contact information
Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Documents
| File name | Description | Last updated |
|---|---|---|
| PAR-25-315-Full-Announcement.html | PAR-25-315 Full Announcement Text | Dec 18, 2024 07:57 PM UTC |
Link to additional information
https://grants.nih.gov/grants/guide/pa-files/PAR-25-315.html
Archived: March 20, 2026
Award
$--
Program Funding
--
Expected awards
$--
Award Minimum
$--
Award Maximum
Funding opportunity number:
PAR-25-315
Cost sharing or matching requirement:
Funding instrument type:
Grant
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Health
Category Explanation:
History
Version:
4
Posted date:
December 18, 2024
Archive date:
March 20, 2026
